Lexicon Pharmaceuticals, Inc.
LXRX
$0.3918
$0.02416.55%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -64.81M | -53.43M | -48.40M | -49.76M | -50.53M |
| Total Depreciation and Amortization | 126.00K | 139.00K | 144.00K | 147.00K | 151.00K |
| Total Amortization of Deferred Charges | 402.00K | 525.00K | 517.00K | 618.00K | 618.00K |
| Total Other Non-Cash Items | 974.00K | -25.00K | 4.08M | 2.72M | 285.00K |
| Change in Net Operating Assets | 9.69M | 4.25M | -11.47M | -4.28M | 7.85M |
| Cash from Operations | -53.62M | -48.54M | -55.13M | -50.55M | -41.62M |
| Capital Expenditure | -307.00K | -250.00K | -- | 0.00 | -83.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.78M | -12.07M | -110.22M | 51.90M | -39.24M |
| Cash from Investing | 53.47M | -12.32M | -110.22M | 51.90M | -39.33M |
| Total Debt Issued | -- | -- | -- | -1.00K | 1.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 1.00K | 88.00K | 0.00 | -- |
| Repurchase of Common Stock | 0.00 | 0.00 | -1.73M | 0.00 | -211.00K |
| Issuance of Preferred Stock | -- | -- | 241.43M | -- | -- |
| Repurchase of Preferred Stock | -10.00K | -15.00K | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -906.00K | 0.00 | -400.00K | -- | -- |
| Cash from Financing | -916.00K | -14.00K | 239.38M | -1.00K | -210.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.07M | -60.88M | 74.03M | 1.35M | -81.16M |
